Tags: Mumbai

Mumbai, Sep 25 Hyderabad-based Pharma company, Natco, which launched a drug similar to Tamiflu, is expecting a turnover of Rs 600 crore by this fiscal end, a top company official said.

"We are expecting a turnover of Rs 600 crore by March 2010. Last year it was Rs 400 crore," Natco Pharma Limited's Product Manager Ambarish Jambhorkar told PTI here after the company came out with drug 'Natflu', available Pan-India to treat Swine Flu, yesterday.

The company is ready with 12.5 lakh capsules to meet the requirements of the Swine Flu situation in the country, he said, adding, "we expect to release 10 million capsules of Natflu by end of October if required."

The drug will be initially sold through the company's own 18 carry and forward agents who will supply 'Natflu' to all those stockists and chemists who have have a Schedule X license.

Currently, the pharma company has tied-up with retail pharmacy chain Medplus, who have applied for the license to sell the drug.

Medplus has 630 outlets across country and currently Natflu will be available at 25 Medplus stores in Hyderabad.

"We are already in talks with several pharma retail outelts to supply Natflu. We expect some deals to close in five to six days," Jambhorkar said. .

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Add to del.icio.us | digg this | Stumble It